Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05494983
Other study ID # PAIN,SLEEP,MICROBIOTA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 4, 2022
Est. completion date January 4, 2026

Study information

Verified date January 2024
Source Université Catholique de Louvain
Contact Gwenaëlle Mievis, PhD Student
Phone +32488451915
Email gwenaelle.mievis@uclouvain.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study in healthy volunteers is to evaluate whether the composition of the gut microbiota and sleep quality influence the susceptibility to develop peripheral and central sensitization of pain pathways. In two different experimental sessions, the following factors will be tested: the influence of the composition of the gut microbiota on the susceptibility to develop peripheral sensitization of nociceptors, and the susceptibility to develop central sensitization of pain pathways. To assess susceptibility to peripheral sensitization, a solution of capsaicin (the active component of chili pepper) will be applied to the skin to induce neurogenic inflammation produced by the release of substances from nociceptors at the peripheral level. This neurogenic inflammation is characterized by a transient redness of the skin that will be measured with an infrared camera. To evaluate the susceptibility to sensitization at the central level, a high frequency electrical stimulation will be applied to the skin. This stimulation induces an increase in sensitivity to mechanical stimulation secondary to central sensitization. The intensity, extent and duration of this mechanical hyperalgesia will therefore be used as a measure of susceptibility to central sensitization. A stool sample and a blood sample will be taken. These samples will be used to characterize the composition of the intestinal microbiota, as well as the metabolites produced by this microbiota. These analyses will allow a comparison of the composition of the microbiota and the metabolites in subjects with a tendency to develop low vs. high sensitization at the peripheral and central levels. Similarly, sleep quality and average sleep duration will be assessed using questionnaires and a measurement of the participant's activity using a wrist movement sensitive bracelet. This information will be used to assess whether some of the interindividual variability in developing peripheral or central sensitization might be related to differences in sleep quality. Finally, systemic inflammation could be a factor modulated by sleep and gut microbiota, influencing pain perception and susceptibility to sensitization. For this reason, systemic pro- and anti-inflammatory cytokines will be measured in the blood sample.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date January 4, 2026
Est. primary completion date June 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Aged between 18 and 65 years - Ability to provide written informed consent - Understanding French Exclusion Criteria: - Current or recent (< 2 months) use of antibiotics, probiotics, fiber supplements or any other molecule that modifies intestinal transit. - Current or recent (< 1 month) use of non-steroidal anti-inflammatory drugs and glucocorticoids - Not willing or able to abstain from acute alcohol intoxication from 7 days prior to each of the two study sessions. - Consumption of alcohol 24 hours prior to each of the two study sessions. - Consumption of hypnotics, centrally-acting analgesics or psychotropic drugs. - Obesity: body mass index > 30 kg.m-2 - Pregnancy and breast-feeding - Diabetes - Cancer - History of inflammatory bowel disease - History of weight-loss surgery (e.g., gastric bypass, gastric band) - History of autoimmune disease (e.g., lupus, rheumatoid arthritis) - Evidence for any other clinically significant disease on direct questioning. - Being a volleyball player due to risk of modified sensitivity of the volar forearm skin. - Any implanted medical device such as cardiac pacemakers, cochlear implants and medication pumps. - Dermatological condition affecting the skin of the volar forearms. - History of an allergy to chili peppers/capsaicin. - Any other reason to exclude the subject according to judgment by the investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Screening visit
The participants will be screened for inclusion and exclusion criteria and will be asked to fill the following questionnaires : Pittsburgh Sleep Quality Index, State and Trait Anxiety Questionnaire, Pain Catastrophizing Scale Fear of Pain Questionnaire, Perceived Stress Scale, Beck Depression Inventory, and questionnaires to assess their health status and the use of medications. A blood sample (to measure pro- and anti-inflammatory cytokines and perform metabolomic analyses) will be obtained. Enrolled participants will be given a wearable actimeter to assess daily total sleep duration during one week before the first experimental session. They will also be requested to complete daily a sleep diary during one week before each experimental session, and a food diary before the first experimental session. A fecal sample (to assess gut microbiota composition and perform metabolomic analyses) will be collected between the screening visit and the first experimental session.
Peripheral sensitization session
The extent of neurogenic inflammation induced by topical capsaicin will be used as a measure of the susceptibility to sensitize at peripheral level. A solution of capsaicin will be applied to the skin of the left or right volar forearm for 30 minutes. The capsaicin-induced neurogenic inflammation can be quantified by assessing the intensity, extent and duration of the capsaicin-induced cutaneous flare response using thermal infrared imaging. Using heat stimuli delivered to the treated skin and surrounding skin, the intensity and duration of the capsaicin-induced hyperalgesia will also be assessed. The experimental session will last approximately two hours.
Central sensitization session
The extent of secondary mechanical hyperalgesia induced by high-frequency electrical stimulation (HFS) of the skin of the left or right volar forearm will be used as a measure of the susceptibility to develop central sensitization. The stimulation will be delivered using a multi-pin electrode designed to preferentially activate epidermal free nerve endings. The strength, spatial extent and duration of the HFS-induced changes in pinprick sensitivity will be characterized by using calibrated mechanical pinprick stimuli. The experimental session will last approximately one hour.

Locations

Country Name City State
Belgium UCLouvain, IONS Woluwe-Saint-Lambert

Sponsors (1)

Lead Sponsor Collaborator
Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between composition of the intestinal microbiota and its metabolites and the susceptibility of sensitization at the peripheral and central levels. A stool sample and a blood sample will be taken. These samples will be used to characterize the composition of the intestinal microbiota, as well as the metabolites produced by this microbiota. These analyses will allow a comparison of the composition of the microbiota and the metabolites in subjects with a tendency to develop low vs. high sensitization at the peripheral and central levels.
The gut microbiota composition will be analyzed using 16S rDNA sequencing. Untargeted metabolite profiling, in fecal and blood samples, will be performed using liquid chromatography (LC) coupled with tandem mass spectrometry (MS-MS) platforms.
one week
Primary Correlation between sleep quality and the susceptibility of sensitization at the peripheral and central levels. Sleep quality will be assessed using questionnaires and a measurement of the participant's sleep using a wrist movement sensitive bracelet. This information will be used to assess whether some of the inter-individual variability in developing peripheral or central sensitization might be related to differences in sleep quality. five weeks
Primary Correlation between sleep duration and the susceptibility of sensitization at the peripheral and central levels. Average sleep duration will be assessed using questionnaires and a measurement of the participant's sleep using a wrist movement sensitive bracelet. This information will be used to assess whether some of the inter-individual variability in developing peripheral or central sensitization might be related to differences in sleep duration. five weeks
Secondary Correlation between levels of systemic pro- and anti-inflammatory cytokines measured by multiplex assays and the susceptibility of sensitization at the peripheral and central levels. Systemic inflammation could be an important factor modulated by sleep and the gut microbiota, influencing nociception and sensitization at peripheral and central levels. Plasma concentrations (pg/mL) of several pro-inflammatory (TNFa, IL-6, IL-1b, MCP-1) and anti-inflammatory (IL-10) markers will me measured using commercially available multiplex assays. one week
Secondary Correlation between pupil diameter and the susceptibility of sensitization at the peripheral and central levels. During sensory stimulation, an infrared camera will be used to measure pupil diameter which has been shown to constitute an indirect correlate of stimulus-evoked phasic variations in activity of the locus coeruleus. five weeks
Secondary Correlation between heart rate variability and the susceptibility of sensitization at the peripheral and central levels. In order to measure autonomic reactivity to pain stimuli, the heart rate variability will be measured by recording electrocardiography during experimental sessions. five weeks
See also
  Status Clinical Trial Phase
Completed NCT04934436 - The Effect of Nursing Care on Circadian Rhythm N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05518955 - VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU N/A
Completed NCT04094376 - Comparison of Morning Operation and Evening Operation on Postoperative Sleep Quality and Pain Under General Anesthesia N/A
Completed NCT04535336 - Vitality Acupunch Exercise Program for Older Adults With Sarcopenia N/A
Completed NCT05316415 - The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy N/A
Recruiting NCT06203184 - The Effect of Video Game-Based Exercises After Open Heart Surgery N/A
Recruiting NCT05970614 - The Effect of Eye Masks and Earplugs In Intensive Care Unit Patients N/A
Completed NCT05975853 - Effects of Binaural Beat Music on Elderly Sleep N/A
Completed NCT06380933 - The Effects of Receiving Warm Footbath With Lavender Essential Oil on Sleep and Comfort N/A
Enrolling by invitation NCT05988164 - "Eye Masks and Post-Surgical Sleep Quality" N/A
Active, not recruiting NCT05116605 - Examining the Differential Effects of Photobiomodulation on Sleep and Performance N/A
Recruiting NCT03627221 - Survey of Students' Sleep Related Outcomes and Sleep Management Network for Sleep N/A
Completed NCT05118191 - Efficacy of Commercially Available Technology in Augmenting Sleep and Well-being N/A
Active, not recruiting NCT05185466 - Self Management Programme on the Sustained Attention and Sleep Quality of the Nurses N/A
Completed NCT05564351 - Ear Plug and Eye Mask Use on Sleep Quality in Intensive Care Patients N/A
Suspended NCT04770181 - New Mothers Alpha-Stim N/A
Completed NCT05462197 - The Influence of Qigong Wuqinxi on Health Status of the Community-Dwelling Older Adults N/A
Completed NCT05081856 - Use Modular Medical Equipment Vehicle in Mobilization of Patient With Chest Tube N/A
Completed NCT03215212 - Effectiveness of Ear Plug, Eye Mask and Ocean Sound on Sleep Quality Among ICU Patients N/A